In addition, genome-wide association studies (GWAS) (7–10) have identified AD risk variants within genes involved in innate immunity (i.e., SPI1, TREM2) (11)), shifting the field to examine a potential causative role of microglia in the pathogenesis of AD. This evidence concerns the gene SPI1 and Alzheimer disease.